These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 22891437)
1. [Mexidant increases the effectiveness of levadopa treatment of Parkinson's disease]. Fedorova TN; Bagyeva GKh; Dobrotvorskaia IS; Stepanova MS; Polevaia EV; Ivanova-Smolenskaia IA; Illarioshkin SN Eksp Klin Farmakol; 2012; 75(6):23-6. PubMed ID: 22891437 [TBL] [Abstract][Full Text] [Related]
2. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease. Koziorowski D; Friedman A Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308 [TBL] [Abstract][Full Text] [Related]
3. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease. Chen JJ; Obering C Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444 [TBL] [Abstract][Full Text] [Related]
4. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias. Storch A; Trenkwalder C; Oehlwein C; Winkelmann J; Polzer U; Hundemer HP; Schwarz J Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640 [TBL] [Abstract][Full Text] [Related]
5. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up]. Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540 [TBL] [Abstract][Full Text] [Related]
6. [The use of antiparkinsonism drugs in 92 cases in Xi'an city]. Zhe X; Qu QM; Wang RL; Cao HM; Qiao J; Guo F Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Oct; 30(10):1065-8. PubMed ID: 20193391 [TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease in the elderly: current management strategies. Aminoff MJ Geriatrics; 1987 Jul; 42(7):31-7. PubMed ID: 3110015 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of Parkinson disease in patients with surgical problems]. Sobolewski P Neurol Neurochir Pol; 2003; 37 Suppl 5():183-8. PubMed ID: 15098345 [TBL] [Abstract][Full Text] [Related]
16. [New therapeutic strategy for Parkinson's disease based on pharmacological profiles]. Ogawa N Nihon Rinsho; 1997 Jan; 55(1):43-51. PubMed ID: 9014422 [TBL] [Abstract][Full Text] [Related]
17. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life. Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551 [TBL] [Abstract][Full Text] [Related]
18. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]
19. Controversies in the therapy of Parkinson's disease. Fahn S Adv Neurol; 1996; 69():477-86. PubMed ID: 8615168 [TBL] [Abstract][Full Text] [Related]
20. Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications. Zoccolella S; Lamberti P; Armenise E; de Mari M; Lamberti SV; Mastronardi R; Fraddosio A; Iliceto G; Livrea P Parkinsonism Relat Disord; 2005 Mar; 11(2):131-3. PubMed ID: 15734674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]